BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1454141)

  • 1. Cerebro-spinal fluid eosinophilia in shunt infections.
    Vinchon M; Vallee L; Prin L; Desreumaux P; Dhellemmes P
    Neuropediatrics; 1992 Oct; 23(5):235-40. PubMed ID: 1454141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid eosinophilia in children with ventricular shunts.
    Fulkerson DH; Boaz JC
    J Neurosurg Pediatr; 2008 Apr; 1(4):288-95. PubMed ID: 18377304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroid treatment for cerebrospinal fluid eosinophilia in a patient with ventriculoperitonial shunt.
    Tangsinmankong N; Nelson RP; Good RA
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):341-2. PubMed ID: 10541427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid eosinophilia associated with intraventricular shunts.
    Bezerra S; Frigeri TM; Severo CM; Santana JC; Graeff-Teixeira C
    Clin Neurol Neurosurg; 2011 Jun; 113(5):345-9. PubMed ID: 21492998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection.
    Fulkerson DH; Sivaganesan A; Hill JD; Edwards JR; Shoja MM; Boaz JC; Jea A
    J Neurosurg Pediatr; 2011 Dec; 8(6):613-9. PubMed ID: 22132920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilia in the cerebrospinal fluid of children with shunts implanted for the treatment of internal hydrocephalus.
    Tzvetanova EM; Tzekov CT
    Acta Cytol; 1986; 30(3):277-80. PubMed ID: 3459327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Codman Medos programmable shunt valve. Evaluation of 53 implantations in 50 patients].
    Belliard H; Roux FX; Turak B; Nataf F; Devaux B; Cioloca C
    Neurochirurgie; 1996; 42(3):139-45; discussion 145-6. PubMed ID: 9084740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustrations and review.
    Komolafe EO; Adeolu AA; Komolafe MA
    Pediatr Neurosurg; 2008; 44(1):36-42. PubMed ID: 18097189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative cerebrospinal fluid wound leakage as a predictor of shunt infection: a prospective analysis of 205 cases. Clinical article.
    Jeelani NU; Kulkarni AV; Desilva P; Thompson DN; Hayward RD
    J Neurosurg Pediatr; 2009 Aug; 4(2):166-9. PubMed ID: 19645552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts.
    Tung H; Raffel C; McComb JG
    J Neurosurg; 1991 Oct; 75(4):541-4. PubMed ID: 1885971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shunt infection: is there a near-miss scenario?
    Thompson DN; Hartley JC; Hayward RD
    J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does CSF composition predict shunt malfunction in tuberculous meningitis?
    Ambekar S; Dwarakanath S; Chandramouli BA; Sampath S; Devi BI; Pandey P
    Indian J Tuberc; 2011 Apr; 58(2):77-81. PubMed ID: 21644394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications of lumboperitoneal shunts. A retrospective study of a series of 195 patients (214 procedures)].
    Duthel R; Nuti C; Motuo-Fotso MJ; Beauchesne P; Brunon J
    Neurochirurgie; 1996; 42(2):83-9; discussion 89-90. PubMed ID: 8952901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of infections after shunting of hydrocephalus. An analysis of 884 shunts].
    Molke Borgbjerg B; Gjerris F; Albeck MJ; Børgesen SE
    Ugeskr Laeger; 1997 May; 159(19):2867-71. PubMed ID: 9190715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is endoscopic third ventriculostomy an internal shunt alone?
    Gangemi M; Maiuri F; Colella G; Magro F; Seneca V; de Divitiis E
    Minim Invasive Neurosurg; 2007 Feb; 50(1):47-50. PubMed ID: 17546544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil activation in the cerebrospinal fluid of children with shunt obstruction.
    Heidemann SM; Fiore M; Sood S; Ham S
    Pediatr Neurosurg; 2010; 46(4):255-8. PubMed ID: 21160233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid shunt infections. Report of 41 cases and a critical review of the literature.
    Quigley MR; Reigel DH; Kortyna R
    Pediatr Neurosci; 1989; 15(3):111-20. PubMed ID: 2702346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.